Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Pharmaceuticals
- Personal Care Products
- Nutraceutical
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 29041
License Grant
Licensor, subsidiary of Australian National University, grants to Canadian Licensee an exclusive, worldwide licence to use and exploit the Licensor Intellectual Property and Results within the Field, including the right to sublicense.
License Property
Licensor possesses intellectual property in the area of phosphosugars and their analogues as anti-inflammatory agents.
LICENSED PATENTS
PHOSPHOSUGAR-BASED ANTI-INFLAMMATORY AND/OR IMMUNOSUPPRESSIVE DRUGS
Australia 41875/89 627500
USA 988001 5506210* granted
NOVEL PHOSPHOSUGARS AND PHOSPHOSUGAR-CONTAINING COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY
Australia PO3098/96
Field of Use
'FIELD' means the use of phosphosugars as neutriceuticals, complementary medicines or cosmetics for the treatment of any applicable condition and expressly excludes (a) the use of phosphosugars as ethical therapeutics; and (b) topical application for wound care; and (c) use of fructose-1,6-diphosphate, administered non-topically, for the treatment or prophylaxis of ischaemic disorders in humans, which includes transplantation and immunosuppression.
IPSCIO Record ID: 29040
License Grant
Licensor, subsidiary of Australian National University, hereby grants to Australian Licensee with effect on and from the Commencement Date an exclusive licence, to- a) Exploit (within the Licensed Field) the Products and Processes in the Territory utilising the Licensor Intellectual Property; and b) use the Licensor Intellectual Property within the Licensed Field for the purposes of further research and development and to Exploit the results of such further research and development.
License Property
Licensor possesses intellectual property in the area of phosphosugars and their analogues as anti-inflammatory agents.
LICENSED PATENTS PHOSPHOSUGAR-BASED ANTI-INFLAMMATORY AND/OR IMMUNOSUPPRESSIVE DRUGS
Australia 41875/89 627500 granted
USA 988001 5506210* granted
NOVEL PHOSPHOSUGARS AND PHOSPHOSUGAR-CONTAINING COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY
Australia PO3098/96 INT on 18 October 1997
Australia 41866/97 examination requested
USA 08/953305 examination requested
Field of Use
'LICENSED FIELD' means the use of phosphosugars as ethical therapeutics and expressly excludes (c) the use of phosphosugars as neutriceuticals, complementary medicines or cosmetics for the treatment of any applicable condition; b) topical application for wound care; and c) the use of fructose-1,6-diphosphate, administered non-topically, for the treatment or prophylaxis of ischaemic disorders in humans, which includes transplantation and immunosuppression.
IPSCIO Record ID: 26973
License Grant
Australian University grants to Australian Licensee an exclusive, worldwide license to use and exploit the University's Intellectual Property and Results within the Field, including the right to sublicense.
License Property
The University possesses intellectual property in the area of phosphosugars and their analogues as anti-inflammatory agents.
STATES PATENT [19] [11] PATENT NUMBER 5,506,210 – Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
4,935,406 – Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
Field of Use
Field means the use of phosphosugars for treatment of inflammatory skin conditions, inflammation resulting from abdominal/pelvic surgery and ocular inflammation.
IPSCIO Record ID: 28216
License Grant
Australian Licensor, an affiliate, hereby grants to Canadian Licensee an exclusive, world-wide sublicence under the Licensed Patent Applications and Licensed Patents, and an exclusive, world-wide sublicence under the New Intellectual Property, to use the Licensed Technology and to make, use and sell any products, compounds, compound uses, processes, applications, methods or procedures within the Field of Use.
License Property
'Licensed Patent Applications' means (I) the patent applications relating to the invention entitled 'Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity', including United State Patent Application No. 08/953305, Australian Application No. 41866/97 and any patent applications filed now or in the future in any country which disclose and claim the same inventions or the priority of Australian Provisional Application PO 3098/96, filed October 18, 1996.
Field of Use
'Field of Use' means arthritis and dermal wrinkles.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
